Rating History for Summit Therapeutics plc (SMMT) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/22/2026 | Mitchell S. Kapoor | Downgrade | Neutral (Buy) |
N/A (N/A) |
17.47 (14.28) |
-18.26% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||


